+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


The Patient Equation. The Precision Medicine Revolution in the Age of COVID-19 and Beyond. Edition No. 1

  • ID: 5185984
  • Book
  • September 2020
  • 288 Pages
  • John Wiley and Sons Ltd

How the data revolution is transforming biotech and health care, especially in the wake of COVID-19 - and why you can’t afford to let it pass you by

We are living through a time when the digitization of health and medicine is becoming a reality, with new abilities to improve outcomes for patients as well as the efficiency and success of the organizations that serve them. In The Patient Equation, Glen de Vries presents the history and current state of life sciences and health care as well as crucial insights and strategies to help scientists, physicians, executives, and patients survive and thrive, with an eye toward how COVID-19 has accelerated the need for change. One of the biggest challenges facing biotech, pharma, and medical device companies today is how to integrate new knowledge, new data, and new technologies to get the right treatments to the right patients at precisely the right times - made even more profound in the midst of a pandemic and in the years to come.

Drawing on the fascinating stories of businesses and individuals that are already making inroads - from a fertility-tracking bracelet changing the game for couples looking to get pregnant, to an entrepreneur reinventing the treatment of diabetes, to Medidata's own work bringing clinical trials into the 21st century - de Vries shares the breakthroughs, approaches, and practical business techniques that will allow companies to stay ahead of the curve and deliver solutions faster, cheaper, and more successfully - while still upholding the principles of traditional therapeutic medicine and reflecting the current environment.

  • How new approaches to cancer and rare diseases are leading the way toward precision medicine
  • What data and digital technologies enable in the building of robust, effective disease management platforms
  • Why value-based reimbursement is changing the business of life sciences
  • How the right alignment of incentives will improve outcomes at every stage of the patient journey

Whether you're a scientist, physician, or executive, you can't afford to let the moment pass: understand the landscape with this must-read roadmap for success - and see how you can change health care for the better.

Note: Product cover images may vary from those shown

Introduction vii

Section 1 From Hippocrates to Epocrates 1

Chapter 1 Before We Cured Scurvy 3

Chapter 2 Inside the Equations 17

Chapter 3 Fitbits, Smart Toilets, and a Bluetooth-enabled Self-driving ECG 43

Section 2 Applying Data to Disease 57

Chapter 4 Ava - Tracking Fertility, on the Road Toward Understanding All of Women’s Health 59

Chapter 5 One Breath, One Drop - Asthma and Diabetes, Chronic Conditions Being Conquered with Technology 69

Chapter 6 Flumoji and Sepsis Watch - Two Approaches to Predicting and Preventing Acute, Life-threatening Conditions Through Smarter Data 81

Chapter 7 Cancer and Phage Therapy - Crafting Custom Treatments Just for You 93

Chapter 8 Castleman Disease - Not One Rare Disease with No Treatments, But Three Rare Diseases . . . with Hope, Thanks to Data 105

Section 3 Building Your Own Patient Equations 113

Chapter 9 The Steam Table 115

Chapter 10 Good Data 133

Chapter 11 Changing Clinical Trials 143

Chapter 12 Disease Management Platforms 175

Section 4 Scaling Progress to the World 191

Chapter 13 The Importance of Collaboration 193

Chapter 14 Value-based Reimbursement 203

Chapter 15 Aligning Incentives 217

Conclusion 231

Acknowledgments 241

About the Authors 243

Index 245

Note: Product cover images may vary from those shown
Glen de Vries
Note: Product cover images may vary from those shown